Pelvic & Urinary Health · Collection 02

She thought she had another UTI.
Her urine culture was negative. Again.

Why urinary burning, urgency, frequency, and discomfort during midlife are not always caused by infection.

The clinical education

The symptoms can overlap. The causes are not interchangeable.

A urinary tract infection is caused by microbes, usually bacteria. Genitourinary syndrome of menopause, or GSM, is a tissue and symptom syndrome related to declining estrogen and other sex-steroid effects. Both can cause burning, urgency, frequency, and discomfort. They do not require the same treatment.

The vagina, vulva, urethra, and lower urinary tract are biologically connected and estrogen responsive. During perimenopause and after menopause, lower estrogen exposure can make vulvovaginal and urethral tissues thinner, drier, less elastic, and more easily irritated. Vaginal pH may rise, protective lactobacilli may decrease, and the local tissue environment may become more vulnerable to irritation and, for some women, recurrent infection.

GSM can present as dryness, burning, itching, rawness, pain with sex, spotting after sex, urinary urgency or frequency, pain with urination, or recurrent urinary tract infection. Some women have several symptoms. Others notice only one. Symptoms may begin during the menopause transition, after natural or surgical menopause, or following treatments that reduce estrogen, including some breast-cancer therapies.

A negative culture does not mean the symptoms are imaginary. It means the explanation may be somewhere beyond bacterial infection.

Why appropriate urine testing matters

Symptoms alone cannot always distinguish an acute UTI from GSM or another pelvic condition. A urinalysis can identify findings such as white blood cells, blood, or nitrites, but a urine culture is the test that attempts to grow and identify bacteria and determine which antibiotics are likely to work. In women being evaluated for recurrent UTI, current guidelines recommend urinalysis and urine culture with each symptomatic episode before treatment when feasible.

The quality and timing of the sample matter. A culture collected after antibiotics have begun may be harder to interpret. A sample reported as mixed flora may represent contamination rather than a true infection and may need to be repeated, sometimes with a catheterized specimen. Conversely, a positive culture without urinary symptoms may represent asymptomatic bacteriuria, which usually should not be treated except in specific circumstances such as pregnancy or before certain urologic procedures.

One negative culture is information, not a verdict

No test should be interpreted in isolation. If symptoms persist, the clinician should review how the sample was collected, whether antibiotics were taken beforehand, whether the symptom pattern truly fits cystitis, and whether a pelvic examination or other evaluation is appropriate. Repeatedly prescribing antibiotics without evidence of infection can delay the correct diagnosis, cause side effects, disrupt the gut and vaginal microbiomes, and contribute to antimicrobial resistance.

The StrongHer truth

Urinary burning deserves both respect and precision. Infection must be identified and treated appropriately. When infection is not demonstrated, the work of understanding the symptom should continue.

A composite experience

“She changed her soap. Her underwear. Her laundry detergent. Nothing helped.”

This educational vignette combines experiences commonly described by women. It is not the story of one identifiable patient.

The burning felt familiar enough that she named it before anyone examined her: another UTI. She recognized the urgency, the repeated trips to the bathroom, and the sting that made her brace before she urinated. She called for treatment because she had been through this before.

But the culture was negative. Again.

She stopped using scented soap. She bought new cotton underwear. She changed laundry detergent, stopped taking baths, drank more water, and wondered whether coffee, exercise, sex, or stress was somehow the problem. Nothing created a reliable pattern, and nothing made the discomfort stay gone.

Sometimes an antibiotic seemed to help for a day or two. Sometimes it did nothing. Once it was followed by vaginal itching that required another treatment. Each recurrence left her more vigilant and less certain. She began planning errands around bathrooms and avoiding intimacy because friction made the burning worse.

What frightened her was not only the discomfort. It was the feeling that every negative test moved her farther away from an answer.

At a later visit, the conversation widened. The clinician asked where the burning was located, whether the tissue felt dry or raw, whether sex had become uncomfortable, when her periods had changed, and whether her symptoms worsened after sitting, exercise, or bladder filling. The examination included the vulva, vagina, urethral area, and pelvic floor, not only another urine cup.

The answer was not “nothing.” The findings were consistent with GSM, with pelvic-floor guarding contributing to the pain. Her plan addressed the tissue changes and the muscle response while leaving room to test for infection whenever a new symptom pattern truly suggested one.

Relief was not instant, but the uncertainty changed. She understood what was being treated, why it could feel like a UTI, and what information would matter if the symptoms returned.

Where women see themselves

Repeated negative cultures should not become repeated dismissal. When a familiar symptom keeps returning without proof of infection, it is reasonable to ask whether the diagnosis, the sample, or the frame of the evaluation needs to change.

Dr. Rhaney’s perspective

When the urine culture is negative, I don’t stop asking questions.

The culture is not an obstacle to work around. It is a piece of clinical evidence that helps me decide where to look next.

When a woman has urinary burning or urgency, infection belongs in the differential. I want to know whether the symptoms began suddenly, whether there is visible blood, fever, flank pain, vaginal discharge, new sexual exposure, or a history of resistant organisms. I also want to know whether the specimen was collected before antibiotics and whether the reported result reflects a likely pathogen, no growth, or contamination.

But if cultures are repeatedly negative, simply changing the antibiotic is not broader clinical reasoning. I step back and ask where the symptom is actually coming from. “Burning with urination” may mean urine touching inflamed vulvar tissue. Urgency may arise from an irritated urethra, overactive bladder, tense pelvic-floor muscles, bladder pain syndrome, or a true infection. Several contributors can coexist.

A negative culture does not end the evaluation. It changes the next question.

The broader differential I consider

Genitourinary syndrome of menopause. I look for dryness, pallor, loss of elasticity, tissue fragility, narrowing, urethral changes, pain with sex, and the relationship between symptoms and the menopause transition, surgical menopause, or estrogen-lowering therapy.

Pelvic-floor dysfunction. Muscles that are persistently tight or tender can produce burning, pressure, painful urination, urgency, incomplete emptying, pain with sex, or symptoms that worsen with stress, prolonged sitting, or activity. This is not weakness alone, and automatic strengthening exercises may not be the right treatment.

Bladder pain syndrome and overactive bladder. Pain or pressure that worsens as the bladder fills and improves after urination suggests a different pattern from an acute bacterial infection. Urgency without pain may fit overactive bladder, but both diagnoses require attention to other possible causes.

Vulvovaginal and dermatologic conditions. Yeast or bacterial vaginitis, contact dermatitis, vulvodynia, lichen sclerosus, lichen planus, herpes or other sexually transmitted infections, fissures, and inflammatory skin disorders can all be experienced as burning near the urinary opening. Read our Vulvar Burning and Vulvodynia collection for a deeper look at this symptom.

Other urinary considerations. Stones, incomplete emptying, urethral pathology, medication effects, prior pelvic radiation, neurologic disease, and, less commonly, malignancy may require consideration based on the history, examination, blood in the urine, and other risk factors.

What a thoughtful evaluation may include

A symptom timeline, medication and treatment history, focused pelvic and vulvar examination, urinalysis and culture when appropriate, assessment of bladder emptying, and targeted testing guided by the findings. Not every woman needs every test. The evaluation should be broad enough to find the cause and disciplined enough to avoid testing without purpose.

Felicia L. Rhaney, MD, FACOG, MSCP
Double board-certified OB-GYN and urogynecologist

The evaluation guide

Before you take another antibiotic, ask these questions.

The point is not to avoid antibiotics when an infection is present. The point is to use them for the right reason, while making sure another treatable cause is not being missed.

Clarify what was tested

A dipstick, urinalysis, and urine culture provide different information. Ask to review the actual culture result and whether the sample was collected before antibiotics.

No growth is different from a low-count result.
Mixed organisms may suggest contamination.
A prior antibiotic can affect interpretation.
A repeat or catheterized sample may sometimes be useful.

Describe the symptom precisely

Note when the symptom began, whether the burning feels internal or external, whether urgency is accompanied by pain, and what happens with bladder filling, urination, sex, exercise, products, or prolonged sitting.

Dryness, rawness, or itching
Pain with penetration
Discharge, odor, sores, or fissures
Visible blood or unusual bleeding
Weak stream or incomplete emptying
Fever, flank pain, nausea, or vomiting

Ask for the examination the pattern supports

If symptoms are persistent, recurrent, external, or associated with vulvovaginal discomfort, a focused pelvic and vulvar examination may reveal information that a urine test cannot. Pelvic-floor tenderness and bladder emptying may also need assessment.

Match treatment to the working diagnosis

Ask what diagnosis is being treated, what improvement should look like, how long it may take, and what the next step will be if the plan does not work.

Questions to bring to the visit

Was a properly collected urine culture obtained before antibiotics were started?
Did the result show one likely urinary pathogen, no growth, or possible contamination such as mixed organisms?
Could the burning be coming from the vulva, vagina, urethra, bladder, or tense pelvic-floor muscles?
Do I have signs of GSM, a vulvovaginal condition, incomplete bladder emptying, or another contributor?
If infection is not demonstrated, what diagnosis are we treating and how will we measure whether the plan works?

If GSM is part of the picture

Treatment should reflect symptom severity, medical history, goals, and preferences. Nonhormonal options include regular vaginal moisturizers for ongoing comfort, lubricants or moisturizers used with sexual activity, and avoidance of products that provoke irritation. Pelvic-floor physical therapy may help when muscle overactivity, tenderness, or guarding is contributing.

Local low-dose vaginal estrogen has the strongest evidence base for many GSM symptoms and is recommended by current specialty guidance for vulvovaginal discomfort, dryness, and pain with sex. In peri- and postmenopausal women with recurrent, culture-documented UTIs, vaginal estrogen is also recommended to reduce future infections when it is medically appropriate. Vaginal DHEA and oral ospemifene may be options for selected vulvovaginal symptoms. These treatments are not interchangeable, and none should be started without considering the individual clinical context.

For breast-cancer survivors

A history of estrogen-dependent breast cancer changes the conversation, but it should not erase it. Nonhormonal treatments are generally considered first. If symptoms remain significant, professional guidance supports individualized shared decision-making about low-dose vaginal estrogen, with oncology involvement particularly for women taking an aromatase inhibitor. The choice should reflect cancer history, current therapy, symptom burden, prior treatment response, and the woman’s values.

If recurrent UTI is the concern

Recurrent UTI is usually defined as at least two infections in six months or three in one year, with documentation that symptoms and bacterial findings occur together. Keep a record of dates, culture organisms, antibiotic susceptibilities, treatments, and response. That history can reveal whether the problem is repeated infection, repeated symptoms without infection, resistant organisms, or more than one condition.

Depending on the pattern, prevention may include vaginal estrogen, hydration and voiding strategies, selected nonantibiotic options, or carefully chosen antibiotic strategies. The right plan is individualized. Repeated empiric treatment without culture confirmation is not the same as a recurrent-UTI plan.

Symptoms that should not wait

Seek prompt medical care for symptoms that may suggest kidney involvement, obstruction, significant bleeding, or another urgent condition.

Fever or chills
Nausea or vomiting
New pain in the back, side, or groin
Visible blood in the urine
Inability to urinate
Rapidly worsening or severe pain
Urinary symptoms during pregnancy

Important: This guide is educational. A negative culture does not rule out every infection or every important condition, and a positive result must still be interpreted alongside symptoms and the quality of the specimen.

Publication and clinical review

Published September 26, 2026. Educational content reviewed September 26, 2026 by Felicia L. Rhaney, MD, FACOG, MSCP. This material is educational and is not a diagnosis or a substitute for individualized medical care.

Selected guidance and evidence

Continue exploring

One symptom pattern. Four ways to understand it.

Return to The Knowledge Hub